SEC Form 5 · accession 0001185185-15-001231
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard K Prins
Director
Period of report
Mar 31, 2015
Accepted (ET)
May 13, 2015 · 8:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Nov 14, 2014 | G | 1,000 | $0.00 | D | 312,000 | D | |
| Common stock | Nov 21, 2014 | G | 1,000 | $0.00 | D | 311,000 | D | |
| Common stock | Dec 1, 2014 | G | 1,000 | $0.00 | D | 310,000 | D | |
| Common stock | Dec 5, 2014 | G | 1,000 | $0.00 | D | 309,000 | D | |
| Common stock | Dec 12, 2014 | G | 1,000 | $0.00 | D | 308,000 | D | |
| Common stock | Dec 19, 2014 | G | 1,000 | $0.00 | D | 307,000 | D | |
| Common stock | Dec 26, 2014 | G | 1,000 | $0.00 | D | 306,000 | D | |
| Common stock | Jan 2, 2015 | G | 1,000 | $0.00 | D | 305,000 | D | |
| Common stock | Jan 9, 2015 | G | 1,000 | $0.00 | D | 304,000 | D | |
| Common stock | Jan 20, 2015 | G | 1,000 | $0.00 | D | 303,000 | D | |
| Common stock | Jan 23, 2015 | G | 1,000 | $0.00 | D | 302,000 | D | |
| Common stock | Feb 6, 2015 | G | 1,000 | $0.00 | D | 301,000 | D | |
| Common stock | Feb 13, 2015 | G | 1,000 | $0.00 | D | 300,000 | D | |
| Common stock | Feb 20, 2015 | G | 1,000 | $0.00 | D | 299,000 | D | |
| Common stock | Feb 27, 2015 | G | 1,000 | $0.00 | D | 298,000 | D | |
| Common stock | Mar 6, 2015 | G | 1,000 | $0.00 | D | 297,000 | D | |
| Common stock | Mar 13, 2015 | G | 1,000 | $0.00 | D | 296,000 | D | |
| Common stock | Mar 20, 2015 | G | 1,000 | $0.00 | D | 295,000 | D | |
| Common stock | Mar 27, 2015 | G | 1,000 | $0.00 | D | 294,000 | D |
Table II — derivative securities
No Table II lines on this filing.